Status In progress
Process CDF Review
ID number 1585

Provisional Schedule

Committee meeting 04 June 2020
Expected publication 12 August 2020

Project Team

Project lead Kate Moore

Email enquiries


Companies sponsors Bristol-Myers Squibb (nivolumab)
Others Department of Health and Social Care
  NHS England
  NHS Bristol North Somerset and South Gloucestershire CCG
  NHS Gloucestershire CCG
  Welsh Government
Patient carer groups Black Health Agency
  Cancer Black Care
  Cancer Equality
  Cancer Laryngectomee Trust
  Changing Faces
  Helen Rollason Cancer Charity
  Independent Cancer Patients Voice
  Let’s Face it
  Macmillan Cancer Support
  Maggie’s Centres
  Marie Curie
  Mouth Cancer Foundation
  Muslim Council of Britain
  National Association of Laryngectomee Clubs
  Oracle Cancer Trust
  Rarer Cancers Foundation
  South Asian Health Foundation
  Specialised Healthcare Alliance
  Swallows Head & Neck Cancer Support Group
  Tenovus Cancer Care
  The Royal Marsden Cancer Charity
Professional groups Association of Cancer Physicians
  British Association of Head and Neck Oncologists
  British Association of Head and Neck Oncology Nurses
  British Association of Oral and Maxillofacial Surgeons
  British Association of Otorhinolaryngologists
  British Dental Health Foundation
  British Dietetic Association- Oncology Specialist Group
  British Geriatrics Society
  British Institute of Radiology
  British Oculoplastic Surgery Society
  British Psychosocial Oncology Society
  British Skull Base Society
  Cancer Research UK
  Royal College of General Practitioners
  Royal College of Nursing
  Royal College of Pathologists
  Royal College of Physicians
  Royal College of Radiologists
  Royal Pharmaceutical Society
  Royal Society of Medicine
  Society and College of Radiographers
  UK Clinical Pharmacy Association
  UK Health Forum
  UK Oncology Nursing Society


Associated guideline groups Cochrane Ear, Nose and Throat Group
  The Head and Neck Cancer Foundation
  Institute of Cancer Research
  MRC Clinical Trials Unit
  National Cancer Research Institute
  National Cancer Research Network
  National Institute for Health Research
  Saving Faces
Associated public health groups Public Health England
  Public Health Wales
Comparator companies Accord Healthcare (docetaxel, methotrexate)
  Actavis UK (docetaxel)
  Dr. Reddy's Laboratories (docetaxel)
  Hospira UK (docetaxel, methotrexate)
  Medac GmbH (docetaxel)
  Pfizer (methotrexate)
  Sanofi (docetaxel)
  Teva UK (docetaxel)
General commentators All Wales Therapeutics and Toxicology Centre
  Allied Health Professionals Federation
  Board of Community Health Councils in Wales
  British National Formulary
  Care Quality Commission
  Department of Health, Social Services and Public Safety for Northern Ireland
  Healthcare Improvement Scotland
  Medicines and Healthcare products Regulatory Agency
  National Association for Primary Care
  National Pharmacy Association
  NHS Alliance
  NHS Commercial Medicines Unit
  NHS Confederation
  Scottish Medicines Consortium
  Welsh Health Specialised Services Committee


Key events during the development of the guidance:

Date Update
30 January 2020 Invitation to participate
24 January 2020 In progress, Topic is in progress

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance